It works by reducing appetite, and researchers are now studying similar drugs, including tirzepatide, which is pending FDA approval for obesity, and retatrutide, which must still undergo further clinical trials on obesity and diabetes
The company claims the program can help you lose an average of 15% to 20% of your body weight within 12 months
2019 Update to: management of hyperglycemia in type 2 Diabetes, 2018
In contrast, NA-DKD shows milder glomerular damage, as it tends to more severe tubulointerstitial and vascular lesions of varying arteriosclerotic degrees [19,46,47]
If youve experienced adverse reactions while taking Wegovy or Ozempic, you may be able to seek compensation through a Wegovy lawsuit
John Whyte, chief medical officer at WebMD and a board-certified internist with expertise in drug development and medical policy, told Flow Space